Stock Price
298.53
Daily Change
-0.25 -0.08%
Monthly
-4.77%
Yearly
3.39%
Q3 Forecast
296.92

Peers Price Chg Day Year Date
Avita Medical 1.34 0.01 0.75% -48.46% Sep/05
Ansell 34.57 0.09 0.26% 15.08% Sep/05
Cochlear 298.53 -0.25 -0.08% 3.39% Sep/05
CSL 209.25 -1.60 -0.76% -31.17% Sep/05
Fisher Paykel Healthcare 37.89 0.76 2.05% 1.31% Sep/05
Healius 0.83 -0.03 -2.94% -50.00% Sep/05
Integral Diagnostics 2.90 0.05 1.75% 11.54% Sep/05
Mesoblast 2.12 0.13 6.53% 124.34% Sep/05
Monash IVF 0.70 -0.01 -0.71% -39.30% Sep/05
Mayne Pharma 5.28 0.01 0.19% 17.33% Sep/05
Nanosonics 4.02 -0.06 -1.47% 12.92% Sep/05
Polynovo 1.53 0.12 8.16% -34.55% Sep/05
Regis Healthcare 7.79 0.07 0.91% 49.23% Sep/05
Ramsay Health Care 33.66 -0.45 -1.32% -15.51% Sep/05
ResMed 42.26 0.79 1.91% 15.56% Sep/05
Sonic Healthcare 22.94 -0.07 -0.30% -15.63% Sep/05
Sigma Healthcare 3.04 0.01 0.33% 139.37% Sep/05
Somnomed 0.71 -0.02 -2.07% 73.17% Sep/05
Telix Pharmaceuticals 13.80 0.03 0.22% -22.21% Sep/05

Indexes Price Day Year Date
ASX200 8871 44.67 0.51% 10.70% Sep/05
Australia All Ordinaries 9140 49.14 0.54% 11.27% Sep/05
AU50 8572 28.50 0.33% 8.23% Sep/05

Cochlear traded at 298.53 this Friday September 5th, decreasing 0.25 or 0.08 percent since the previous trading session. Looking back, over the last four weeks, Cochlear lost 4.77 percent. Over the last 12 months, its price rose by 3.39 percent. Looking ahead, we forecast Cochlear to be priced at 296.92 by the end of this quarter and at 292.13 in one year, according to Trading Economics global macro models projections and analysts expectations.